Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults

This double-blind study (n=22) investigated the effects of microdosing LSD (13μg & 26μg) on resting-state electroencephalography (EEG) and event-related potential (ERP) in healthy adults. The study found that microdoses of LSD produced desynchronization patterns similar to those reported with higher doses of psychedelics, leading the authors to believe that microdoses of LSD may produce therapeutic effects in the absence of a full psychedelic experience.

Abstract of Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults

Rationale: Classical psychedelics, including psilocybin and lysergic acid diethylamide (LSD), are under investigation as potential therapeutic agents in psychiatry. Whereas most studies utilize relatively high doses, there are also reports of beneficial effects of “microdosing,” or repeated use of very low doses of these drugs. The behavioural and neural effects of these low doses are not fully understood.

Objectives: To examine the effects of LSD (13 μg and 26 μg) versus placebo on resting-state electroencephalography (EEG) and event-related potential (ERP) responses in healthy adults.

Methods: Twenty-two healthy men and women, 18 to 35 years old, participated in 3 EEG sessions in which they received a placebo or LSD (13 μg and 26 μg) under double-blind conditions. During each session, participants completed drug effect and mood questionnaires at hourly intervals, and physiological measures were recorded. During the expected peak drug effect, EEG recordings were obtained, including resting-state neural oscillations in scalp electrodes over default mode network (DMN) regions and P300, N170, and P100 ERPs evoked during a visual oddball paradigm.

Results: LSD dose-dependently reduced oscillatory power across the delta, theta, alpha, beta, and gamma frequency bands during both eyes closed and eyes open resting conditions. During the oddball task, LSD dose-dependently reduced ERP amplitudes for P300 and N170 components and increased P100 latency. LSD also produced dose-related increases in a positive mood, elation, energy, and anxiety and increased heart rate and blood pressure. On a measure of altered states of consciousness, LSD dose-dependently increased Blissful State, but not other indices of perceptual or sensory effects typical of psychedelic drugs. The subjective effects of the drug were not correlated with the EEG measures.

Conclusions: Low doses of LSD produced broadband cortical desynchronization over the DMN during resting state and reduced P300 and N170 amplitudes, patterns similar to those reported with higher doses of psychedelics. Notably, these neurophysiological effects raise the possibility that very low doses of LSD may produce subtle behavioural and perhaps therapeutic effects that do not rely on the full psychedelic experience.”

Authors: Conor H. Murray, Ilaria Tare, Claire M. Perry, Michael Malina, Royce Lee & Harriet de Wit

Notes on Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults

Despite a large body of research indicating the positive outcomes of microdosing, many studies use self-reported measures such as surveys and questionnaires. As a result, cannot be used as reliable clinical evidence. Furthermore, although a significant number of positive anecdotal reports from people who microdose exist, barely any scientific studies have taken place exploring both the physiological and pharmacological effects of microdosing. Such studies are needed to determine the safety and efficacy of microdosing and to avoid any potential harm.

The present study is one of the first studies to examine the effects microdosing LSD has on cognitive processes in healthy adults. This double-blinded placebo-controlled study assessed electroencephalography (EEG) and event-related potential (ERP) responses, techniques commonly used in psychedelic studies involving larger doses, to determine the effect 13ug or 26ug of LSD has on human brain function. In comparison to fMRI, EEG is much better at capturing events over time, but at lower ‘resolution’.

The study found that:

  • Low doses of LSD reduced oscillatory power across frequency bands indicative of cortical desynchronization during rest, both with eyes closed and eyes open. Effects were dose dependent i.e the higher dose of LSD (26μg) produced greater effects.
  • The observed cortical desynchronization was similar to that found in studies using higher doses of psychedelics.
  • Participants in the study also reported increases in positive mood, energy, elation, anxiety and intellectual efficiency.

This study provides hope that low doses of LSD may produce behavioural and even therapeutics effects in the absence of a full psychedelic experience. Such findings may indicate that repeated low doses of psychedelics, in combination with sufficient support and preparation, may provide an alternative treatment model to the current high dosing procedures.

This way, similar outcomes could be reached without the costs associated with having one or two trained therapists sitting a full psychedelic experience. Using a microdose could also open up these forms of treatment to those not wanting to have a full psychedelic experience or not being able to for health (or again costs) reasons.

Summary of Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults

Low doses of LSD have been shown to improve ratings of vigour, decrease attentional lapses, and affect time perception, but they have few other effects on mood or cognition. However, it is possible that low doses of LSD subtly change neural function, which ultimately affects behaviour.

LSD and psilocybin are partial agonists of serotonin receptors, with some affinity to dopamine receptors. They stimulate the release of glutamate, which increases the excitability of cortical networks.

Several studies have investigated the effects of psychedelic drugs on functional connectivity in the brain using functional magnetic resonance imaging (fMRI), most at relatively high doses. These studies indicate that psychedelic drugs increase functional connectivity across networks while decreasing connectivity within networks.

Several studies have examined the effects of psychedelic drugs on EEG, particularly the effects of LSD and psilocybin on the posterior cingulate cortex (PCC), which is a major hub of the default mode network (DMN), a major resting-state network implicated in self-referential processing. Psilocybin reduced ERPs in one study, and N170 responses to fearful faces in another study. These findings are consistent with fMRI findings that psychedelic drugs increase neural complexity while reducing event-related neural responses.

To access this content, you must purchase one of the following memberships: Sprout Membership, Pro Membership, Pro Membership Unlimited, Business Membership or Business Membership Unlimited. The membership will give you access to exclusive data, including summaries of psychedelic research papers, extended company info, and our member-only visualisations. Save yourself multiple hours each week by accessing Blossom’s resource library.

Find this paper

Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults

https://doi.org/10.1007/s00213-021-05991-9

Paywall | Google Scholar | Backup | 🕊

Cite this paper (APA)

Murray, C. H., Tare, I., Perry, C. M., Malina, M., Lee, R., & de Wit, H. (2022). Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults. Psychopharmacology, 1-13.

Study details

Compounds studied
LSD

Topics studied
Neuroscience Microdosing

Study characteristics
Original Double-Blind Within-Subject

Participants
22 Humans

Authors

Authors associated with this publication with profiles on Blossom

Harriet de Wit
Harriet de Wit is a Professor of Psychiatry and Behavioral Neuroscience at the University of Chicago. Her research focuses on the physiological, subjective (i.e., mood-altering), and behavioral effects of drugs in healthy human volunteers.

Institutes

Institutes associated with this publication

University of Chicago
Research with psychedelics is taking place at the Human Behavioral Pharmacology Lab at the University of Chicago.

Compound Details

The psychedelics given at which dose and how many times

Placebo 13 - 26
μg | 2x